Follow
Vyshnavi Tallapaneni
Vyshnavi Tallapaneni
Postdoctoral researcher at Columbia university
Verified email at cumc.columbia.edu
Title
Cited by
Cited by
Year
Virtual high throughput screening: Potential inhibitors for SARS-CoV-2 PLPRO and 3CLPRO proteases
D Jade, S Ayyamperumal, V Tallapaneni, CMJ Nanjan, S Barge, S Mohan, ...
European journal of pharmacology 901, 174082, 2021
362021
Formulation, characterization and in vitro evaluation of dual-drug loaded biomimetic chitosan-collagen hybrid nanocomposite scaffolds
V Tallapaneni, L Mude, D Pamu, V Karri
Journal of Medicinal and Chemical Sciences 5, 1059-1074, 2022
222022
Curcumin loaded ethosomal vesicular drug delivery system for the treatment of melanoma skin cancer
RK Kollipara, V Tallapaneni, BKR Sanapalli, GV Kumar, VVSR Karri
Research Journal of Pharmacy and Technology 12 (4), 1783-1792, 2019
162019
Biomedical applications of electrospun nanofibers in the management of diabetic wounds
D Pamu, V Tallapaneni, VVSR Karri, SK Singh
Drug Delivery and Translational Research, 1-9, 2022
152022
Acellular scaffolds as innovative biomaterial platforms for the management of diabetic wounds
V Tallapaneni, C Kalaivani, D Pamu, L Mude, SK Singh, VVSR Karri
Tissue Engineering and Regenerative Medicine 18 (5), 713-734, 2021
102021
Molecular docking analysis of α-Topoisomerase II with δ-Carboline derivatives as potential anticancer agents
S Ayyamperumal, DJ Dhananjay, V Tallapaneni, S Mohan, S Basappa, ...
Bioinformation 17 (1), 249, 2021
52021
Emerging role of inorganic and metal nanoparticles for the delivery of combination of drugs in wound healing and tissue regeneration
V Tallapaneni, D Pamu, TN Shilpa, VVSR Karri, SK Mohankumar
Nanocarriers for the Delivery of Combination Drugs, 195-226, 2021
42021
In silico screening of FDA approved drugs against ACE2 receptor: potential therapeutics to inhibit the entry of SARS-CoV-2 to human cells
S Ayyamperumal, D Jade, V Tallapaneni, MJN Chandrasekar, MJ Nanjan
Journal of Biomolecular Structure and Dynamics 40 (21), 11383-11394, 2022
32022
Downregulation of NT5C3 gene expressions by elastin-like polypeptide gemcitabine conjugate for ovarian cancer therapy
D Ramamurthi, J Selvaraj, PV Raj, V Tallapaneni, MJN Chandrasekar
Journal of Drug Delivery Science and Technology 76, 103821, 2022
32022
Structural and functional analysis of Chitinase-IV of Brassica juncea: molecular modeling and dynamic simulation study
S Ayyamperumal, D Jade, V Tallapaneni, S Mohan, S Barge, ...
Journal of Biomolecular Structure and Dynamics 40 (4), 1830-1842, 2022
32022
Dual-drug loaded biomimetic chitosan-collagen hybrid nanocomposite scaffolds for ameliorating potential tissue regeneration in diabetic wounds
V Tallapaneni, D Pamu, L Mude, VVSR Karri
bioRxiv, 2022.02. 16.480700, 2022
32022
Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA …
L Mude, S Jupudi, AK Swaroop, V Tallapaneni, VVSR Karri
Journal of Biomolecular Structure and Dynamics 42 (5), 2437-2448, 2024
22024
Growth factor loaded thermo-responsive injectable hydrogel for enhancing diabetic wound healing
V Tallapaneni, L Mude, D Pamu, VR Palanimuthu, SV Magham, ...
Gels 9 (1), 27, 2022
22022
Micro and nanoparticles for the delivery of growth factors in diabetic wounds
S Sanju, V Tallapaneni, S Narukulla, D Pamu, L Mude, VVSR Karri
Journal of Medical Pharmaceutical and Allied Sciences 10 (5), 3552-3559, 2021
12021
Synbiotics: Safety Assessment and Role in the Prevention of Diseases
L Mude, V Tallapaneni, R Kalaivanan, VVSR Karri
Synbiotics in Human Health: Biology to Drug Delivery, 363-376, 2024
2024
Preliminary hypothetical assessment and in silico molecular docking of statin to VEGFR2 and VEGFR3 protein complex associated with angiogenesis and lymphangiogenesis in …
D Pamu, S Ayyamperumal, M Manne, V Tallapaneni, CJN Moola, ...
Journal of Applied Pharmaceutical Science 13 (1), 009-020, 2023
2023
Brain targeted intra nasal acyclovir lipid nanoparticles; in-vitro characterization and in-vivo biodistribution studies.
K Selvaraj, G Kuppusamy, V Tallapaneni, VV Satyanarayana Reddy Karri
Pakistan Journal of Pharmaceutical Sciences 35 (5), 2022
2022
The Role of Computers and Ethics in Pharmaceutical Research
V Tallapaneni, M Bhaskaran, VVSR Karri, M Parvathaneni
NeuroQuantology 20 (11), 7987, 2022
2022
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACEUTICAL SCIENCES
M Dineshkumar, V Tallapaneni, VVSR Karri
2020
Structural and functional analysis of Chitinase-IV of Brassica juncea: molecular modeling and dynamic simulation study
DJ Selvaraj Ayyamperumal, V Tallapaneni, S Mohan, S Barge, ...
The system can't perform the operation now. Try again later.
Articles 1–20